Continuous Peripheral Nerve Block Catheter Market : Global Industry Analysis and Opportunity Assessment, 2036

How big is the Continuous Peripheral Nerve Block Catheter Market in 2026?

USD 699.4 million in 2026, reaching USD 1,264.4 million by 2036 at a 6.1% CAGR

The continuous peripheral nerve block catheter market is estimated at USD 699.4 million in 2026 and is forecast to reach USD 1,264.4 million by 2036 at a 6.1% CAGR. Demand is shaped by post-surgical pain management, where stimulating catheters deliver continuous regional anesthesia for lower extremity surgery. Stimulating Catheters account for 38.0% of Product demand in 2026, while Ultrasound based insertion holds 67.2% of insertion technique.

The market was valued at USD 659.2 million in 2025. Growth reflects rising surgical volume and the shift toward opioid-sparing regional anesthesia. Demand is shaped by hospitals and ambulatory surgical centers adopting continuous peripheral nerve block catheters for post-operative pain control across lower extremity, upper extremity, and trauma procedures.

Continuous peripheral nerve block catheters are consumable anesthesia devices tied to surgical pain management. Buyers judge catheters through placement accuracy and continuous delivery. Procurement centers on hospital anesthesia and surgical budgets.

Summary of the Continuous Peripheral Nerve Block Catheter Market

Market Signal	Commercial Impact
Demand and Growth Drivers	Demand is driven by opioid-sparing regional anesthesia for surgery, aided by ultrasound-guided catheter placement. Hospitals use stimulating catheters for continuous regional anesthesia in lower extremity surgery requiring sustained pain control. Opioid-sparing pain management practice drives adoption of continuous nerve block over systemic analgesia. Ultrasound-guided insertion improves placement accuracy, expanding catheter use across surgical procedures.
Product and Segment View	Stimulating catheters and ultrasound-based insertion lead the mix, anchored by lower-extremity surgery. Stimulating Catheters account for 38.0% of Product demand, anchored by accurate nerve localization for block placement. Ultrasound Based Insertion leads Insertion Technique at 67.2% share as guided placement improves accuracy. Lower Extremity Surgeries lead Indication as they are the highest-volume continuous nerve block application.
Geography and Competitive Outlook	India leads growth on surgical volume, while makers compete on placement accuracy and insertion systems. India is forecast to record 5.7% CAGR by 2036 due to surgical volume growth and regional anesthesia adoption. Japan and China follow at 5.2% and 4.8% CAGR as surgical capacity and pain management practice expand. B. Braun and Teleflex compete with Pajunk through catheter quality and insertion systems. Placement accuracy and supply separate suppliers.
Analyst Opinion	Accurate stimulating-catheter placement with ultrasound guidance will win as opioid-sparing anesthesia drives adoption. Suppliers that pair accurate stimulating catheter placement with ultrasound-guided insertion will hold the strongest position as opioid-sparing regional anesthesia drives continuous nerve block adoption. Adoption is increasing due to ultrasound-guided continuous nerve block replacing systemic opioid analgesia. - Anurag Sharma, Principal Consultant at Future Market Insights

Why is the Continuous Peripheral Nerve Block Catheter Market growing?

Rising Stimulating Catheter and ultrasound-insertion demand in surgical pain management

• Sustained sourcing of stimulating catheters is shaped by hospitals delivering continuous regional anesthesia for lower extremity surgery.
• India is leading the way with growth of 5.7%, driven by surgical volume growth, regional anesthesia adoption, and pain management practice.
• The insertion segment is led by Ultrasound Based Insertion at 67.2% share, supported by guided placement accuracy.

Demand is rising because surgical volume and opioid-sparing pain management require continuous regional anesthesia. Adoption is increasing due to ultrasound-guided catheter insertion, which improves placement accuracy and block reliability, with stimulating catheters delivering sustained post-operative pain control across lower extremity, upper extremity, and trauma procedures in hospitals and surgical centers.

How is the Continuous Peripheral Nerve Block Catheter Market segmented?

By Product, Insertion Technique, Indication and End User

• Stimulating catheters are projected to lead product demand with 38.0% share in 2026 due to accurate nerve localization.
• Ultrasound based insertion is expected to lead insertion technique with 67.2% share in 2026 as guided placement improves accuracy.
• Hospitals are forecast to lead end user with 75.0% share in 2026 as surgical anesthesia concentrates in hospitals.

Why do Stimulating Catheters lead the Continuous Peripheral Nerve Block Catheter Market?

• Stimulating catheters are expected to hold 38.0% share in 2026 because they provide accurate nerve localization for block placement.
• Their placement reliability anchors demand across lower extremity and trauma procedures.

How big is the insertion technique segment in the Continuous Peripheral Nerve Block Catheter Market?

• Ultrasound based insertion forms the leading technique at 67.2% share, anchored by guided placement accuracy.
• Nerve stimulation based insertion follows where ultrasound access is limited.

Which indication leads the market?

• Lower extremity surgeries lead Indication as they are the highest-volume continuous nerve block application.
• Trauma and upper extremity surgeries follow as regional anesthesia use extends.

Which end user leads procurement?

• Hospitals lead end user at 75.0% share as surgical anesthesia concentrates in hospitals.
• Ambulatory surgical centers and pain clinics follow as outpatient regional anesthesia extends.

What drives and restrains the Continuous Peripheral Nerve Block Catheter Market?

Driven by surgical volume and opioid-sparing practice; restrained by placement skill and catheter cost

Surgical volume and opioid-sparing pain management support adoption while anesthesiologist placement skill and catheter cost limit access in lower-resource settings.

• Driver: Hospitals delivering continuous regional anesthesia for lower extremity surgery use stimulating catheters with ultrasound guidance, generating recurring demand tied to surgical pain management.
• Restraint: Surgical centers in lower-resource settings face the requirement for skilled ultrasound-guided placement and catheter cost that limit continuous nerve block adoption.
• Opportunity: Ultrasound-guided insertion and ambulatory pain management can widen adoption by extending continuous nerve block into outpatient surgical settings.

Surgical pain management is lifting catheter demand as hospitals adopt opioid-sparing regional anesthesia. Stimulating catheters anchor demand while ultrasound guidance improves placement.

The market is led by structural demand from hospital surgical anesthesia. Stimulating catheters remain the leading product, while non-stimulating catheters serve specific uses. Constraints include placement skill, catheter cost, and competition from single-injection blocks.

Which factors support expansion in the Continuous Peripheral Nerve Block Catheter Market?

Surgical volume and ultrasound insertion support market value across hospital and surgical-center channels

• Market value is supported by continuous catheter consumption tied to each surgical procedure.
• Supplier pricing reflects placement accuracy and catheter design before supply reliability affects renewal.
• Anesthesia teams compare placement accuracy and reliability before standardizing on a catheter.

Which countries are growing fastest in the Continuous Peripheral Nerve Block Catheter Market?

Country	CAGR
India	5.7%
Japan	5.2%
China	4.8%
Germany	4.1%
USA	3.8%

Source: Future Market Insights analysis, 2026.

How do country-level CAGRs compare in the Continuous Peripheral Nerve Block Catheter Market?

The global continuous peripheral nerve block catheter market is projected to expand at 6.1% from 2026 to 2036. The study covers more than 30 countries, and the primary markets are listed below.

• India is forecast to record 5.7% CAGR by 2036 as surgical volume growth and regional anesthesia adoption accelerate.
• Japan is expected to expand at 5.2% CAGR through 2036 as aging-population surgical demand grows.
• China is estimated to grow at 4.8% CAGR by 2036 as surgical capacity and pain management practice expand.
• Germany is projected to rise at 4.1% CAGR through 2036 as established regional anesthesia practice continues.
• The USA is forecast to post 3.8% CAGR by 2036 as a mature regional anesthesia base shapes demand.

Who are the leading companies in the Continuous Peripheral Nerve Block Catheter Market?

B. Braun Melsungen, Teleflex, Pajunk, Halyard Health, and Epimed International

B. Braun Melsungen and Teleflex compete through catheter quality and regional anesthesia portfolios. Placement accuracy remains a further point of differentiation. Pajunk and Halyard Health compete on nerve block catheter systems, while Epimed International holds positions in pain management catheters. These overlap with broader anesthesia and surgical consumable buying paths.

Buyers compare suppliers on placement accuracy, catheter design, and supply reliability. Hospitals standardize on catheters with reliable nerve localization and consistent supply. Anesthesia teams favor suppliers offering ultrasound-compatible stimulating catheters for accurate block placement.

Who are the key players in the Continuous Peripheral Nerve Block Catheter Market?

Key global companies leading the Continuous Peripheral Nerve Block Catheter Market include:

• B. Braun Melsungen, Teleflex, and Pajunk maintain leading positions through nerve block catheter portfolios, placement accuracy, and hospital relationships across global markets.
• Anesthesia device specialists such as Halyard Health, Epimed International, and Ambu compete through catheter and insertion systems.
• Specialist and emerging providers such as Laerdal and Medline target surgical pain management supply to establish positions and scale.

How do top Continuous Peripheral Nerve Block Catheter Market companies compare?

B. Braun and Teleflex lead on scale; Pajunk also has a global footprint, while Halyard and Epimed are more catheter-concentrated.

Company	Product Breadth	Placement Accuracy	Distribution Scale	Geographic Footprint
B. Braun Melsungen	High	High	Strong	Europe-led
Teleflex	High	High	Strong	Global
Pajunk	Moderate	High	Moderate	Europe-led
Halyard Health	Moderate	Moderate	Strong	Americas-led
Epimed International	Moderate	High	Moderate	Global

Source: Future Market Insights competitive analysis, 2026.

Key Developments in the Continuous Peripheral Nerve Block Catheter Market

• In January 2025, CMS began providing separate Medicare reimbursement for Avanos Medical's ON-Q elastomeric and ambIT electronic infusion pumps under the NOPAIN Act, with CMS confirming continued eligibility for 2026 and expanding the qualifying product list. Dedicated reimbursement codes remove a longstanding adoption barrier in outpatient and ambulatory settings. Payment evidence supports hospital purchasing committees evaluating non-opioid infusion systems before standardising post-surgical pain management pathways. 

• In August 2025, SmartAlpha received FDA 510(k) clearance for Nerveblox, an AI software solution that identifies 50 anatomical structures across 12 nerve block procedures in real time during ultrasound-guided regional anesthesia, with additional regulatory approvals granted in Europe, the UK and Australia earlier in 2025. AI-assisted guidance lowers the skill threshold for catheter placement under ultrasound. Clearance evidence supports anaesthesia departments assessing technology that improves catheter positioning accuracy before expanding peripheral nerve block programmes. 

• In October 2025, SmartAlpha and GE HealthCare announced a collaboration to commercialise Nerveblox as integrated software within GE HealthCare's Venue point-of-care ultrasound platform, introduced to US anaesthesiologists at the ASA annual meeting. Major OEM integration embeds nerve-block AI directly into installed ultrasound hardware at scale. Distribution evidence supports providers evaluating whether existing GE ultrasound equipment can support CPNB catheter placement without additional capital outlay. 

Key Players in the Continuous Peripheral Nerve Block Catheter Market

Global Anesthesia Device Leaders

• B. Braun Melsungen AG
• Teleflex Incorporated
• Pajunk GmbH

Nerve Block Catheter Specialists

• Halyard Health, Inc.
• Epimed International
• Ambu A/S

Regional and Emerging Players

• LAERDAL
• MEDLINE
• TELEFLEX MEDICAL

Continuous Peripheral Nerve Block Catheter Market - Scope & Definition

Attribute	Detail
Market Definition	Continuous peripheral nerve block catheters used to deliver regional anesthesia for post-surgical pain management, spanning stimulating and non-stimulating catheter types across insertion techniques
Functions Covered	Continuous regional anesthesia, post-operative pain control, and nerve block placement across procedures
Applications Covered	Lower extremity surgery, trauma cases, upper extremity surgery, and pain management
End-Use Industries	Hospitals, ambulatory surgical centers, pain management clinics, and homecare settings
Inclusions	Stimulating and non-stimulating catheters, insertion systems, and continuous nerve block consumables
Exclusions	Single-injection nerve blocks, neuraxial catheters outside peripheral nerve block, and non-anesthesia catheters

Continuous Peripheral Nerve Block Catheter Market - Research Methodology

Method	Description
Primary Research	FMI analysts gathered input from manufacturers, service providers, technology developers, distributors, end users, procurement teams, and subject-matter experts. Interviews examined purchasing decisions, product or service evaluation, adoption barriers, approval requirements, pricing considerations, and expectations for technical or commercial support. Respondents were also asked what evidence is required before a trial, pilot, or initial order develops into regular purchasing.
Desk Research	Desk research covered government statistics, regulatory publications, trade data, industry associations, technical literature, standards, company filings, product information, and official corporate announcements. Sources were reviewed for relevance, publication date, geographic coverage, and consistency with the defined market scope. Claims relating to performance, applications, approvals, capacity, investment, and commercial activity were retained only when supported by credible public evidence.
Market Sizing & Forecasting	The market model combined the baseline value with historical performance, segment structure, pricing and volume indicators, adoption levels, company participation, and country-level demand conditions. Forecast assumptions considered economic activity, investment trends, regulatory developments, technology adoption, purchasing cycles, supply availability, and barriers to wider market use. Segment and regional estimates were reconciled before the final market total was calculated.
Data Validation	Estimates were checked against multiple independent indicators, including public data, company activity, trade patterns, industry developments, and findings from primary interviews. Validation also tested whether products, services, applications, and company revenues fell within the defined market boundaries. Adjacent categories, unsupported claims, overlapping revenues, and activities without direct market relevance were excluded to reduce double counting and maintain consistency across segments and countries.

What does the Continuous Peripheral Nerve Block Catheter Market report cover?

2021 to 2025 history and 2026 to 2036 forecasts across all segments and 30+ countries

Parameter	Details
Forecast period	2026 to 2036
Historical period	2021 to 2025
Quantitative unit	Value in USD million
By Product	Stimulating Catheter, Open Tip Stimulating Catheter, Closed Tip Stimulating Catheter, Non-Stimulating Catheter, Open Tip Non-Stimulating, Closed Tip Non-Stimulating
By Insertion technique	Ultrasound Based Insertion, Nerve Stimulation Based Insertion
By Indication	Lower Extremity Surgeries, Trauma Cases, Upper Extremity Surgeries, Pain Management, Other Indications
By End user	Hospitals, Ambulatory Surgical Centers, Pain Management Clinics, Homecare Settings
Regions covered	North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia and Pacific, Middle East and Africa
Countries covered	USA, India, Japan, China, Germany, and other major markets
Key companies profiled	B. Braun Melsungen, Teleflex, Pajunk, Halyard Health, Epimed International, Ambu, Laerdal, Medline
Approach	Bottom-up procedure-based approach using surgical volume, catheter use per procedure, product mix, and supplier disclosures

Market Segmentation Analysis

Continuous Peripheral Nerve Block Catheter Market Segmented by Product:

• Stimulating Catheter
  • Electrical Nerve Localization Catheters
    • Single Shot Placement Support
    • Continuous Infusion Pain Control
  • Echogenic Stimulating Catheters
    • Ultrasound Visible Tip Design
    • Improved Placement Accuracy
  • Multi Port Stimulating Catheters
    • Enhanced Drug Distribution
    • Extended Analgesia Delivery
• Open Tip Catheter Stimulating Catheter
  • End Hole Designs
  • Soft Closed Tip Designs
• Closed Tip Catheter Stimulating Catheter
  • Distal Opening Designs
  • Reinforced Open Tip Designs
• Non-Stimulating Catheter
  • Standard Perineural Catheters
    • Routine Postoperative Pain Management
    • General Orthopedic Procedures
  • Echogenic Non Stimulating Catheters
    • Ultrasound Guided Placement
    • Reduced Procedure Time
  • Flexible Soft Tip Catheters
    • Patient Comfort Design
    • Lower Tissue Irritation Use
• Open Tip Catheter Non-Stimulating Catheter
• Closed Tip Catheter Non-Stimulating Catheter
• Over-The-Needle Catheter

Continuous Peripheral Nerve Block Catheter Market Segmented by Insertion Technique:

• Ultrasound Based Insertion
  • Real Time Visualization
    • Improved Placement Accuracy
    • Reduced Complication Risk
  • Echogenic Catheter Systems
    • Enhanced Needle Visibility
    • Faster Procedure Workflow
• Nerve Stimulation Based Insertion
  • Traditional Localization Methods
    • Electrical Response Guidance
    • Broad Clinical Adoption
  • Combined Guidance Methods
    • Stimulator Plus Ultrasound Use
    • High Precision Placement

Continuous Peripheral Nerve Block Catheter Market Segmented by Indication:

• Lower Extremity Surgeries
• Trauma Cases
• Upper Extremity Surgeries
• Pain Management
• Other Indications

Continuous Peripheral Nerve Block Catheter Market Segmented by End User:

• Hospitals
  • Public Hospitals
    • High Volume Surgical Centers
    • Teaching Hospital Programs
  • Private Hospitals
    • Premium Pain Management Services
    • Multispecialty Surgery Units
• Ambulatory Surgical Centers
  • Day Care Surgery Centers
    • Same Day Orthopedic Procedures
    • Fast Recovery Programs
  • Specialty Procedure Centers
    • Regional Block Focused Use
    • Cost Efficient Surgeries
• Pain Management Clinics
  • Chronic Pain Centers
    • Long Term Catheter Therapy
    • Interventional Pain Services
  • Outpatient Infusion Clinics
    • Follow Up Catheter Care
    • Customized Analgesia Programs
• Homecare Settings
  • Post Discharge Patients
    • Portable Pump Based Therapy
    • Remote Monitoring Support
  • Rehabilitation Centers
    • Mobility Recovery Programs
    • Extended Pain Relief Use

Continuous Peripheral Nerve Block Catheter Market by Region:

• North America
  • USA
  • Canada
• Latin America
  • Brazil
  • Mexico
  • Chile
  • Rest of Latin America
• Western Europe
  • Germany
  • UK
  • Italy
  • Spain
  • France
  • Nordic
  • BENELUX
  • Rest of Western Europe
• Eastern Europe
  • Russia
  • Poland
  • Hungary
  • Balkan & Baltic
  • Rest of Eastern Europe
• East Asia
  • China
  • Japan
  • South Korea
• South Asia and Pacific
  • India
  • ASEAN
  • Australia & New Zealand
  • Rest of South Asia and Pacific
• Middle East & Africa
  • Kingdom of Saudi Arabia
  • Other GCC Countries
  • Türkiye
  • South Africa
  • Other African Union
  • Rest of Middle East & Africa

Research Sources and Bibliography

• World Health Organization. (2025, October). Global surgery and anesthesia capacity report.
• Organisation for Economic Co-operation and Development. (2025, November). Health at a Glance: surgical procedure volumes.
• USA Food and Drug Administration. (2026, February 9). Device clearances for nerve block catheters.
• European Commission. (2025, December 6). Medical Device Regulation guidance for anesthesia devices.
• National Health Commission of China. (2025, September). Surgical and anesthesia capacity bulletin.
• B. Braun Melsungen AG. (2026, February 17). 2025 annual report and anesthesia portfolio overview.
• Teleflex Incorporated. (2026, February 20). 2025 results and anesthesia products update.

This bibliography is provided for reader reference and is not exhaustive.

This Report Answers

• Market size estimates for 2026 and forecasts through 2036 for the Continuous Peripheral Nerve Block Catheter Market.
• Analysis of product demand across stimulating and non-stimulating catheters with insertion techniques.
• Country-level growth analysis covering India and Japan with China, Germany and USA outlooks.
• Evaluation of company positioning across B. Braun and Teleflex with Pajunk, Halyard Health and Epimed.
• Assessment of drivers and restraints with procurement patterns across hospital and surgical-center channels.